Literature DB >> 6367871

Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension.

E Fritschka, R Gotzen, R Kittler, M Schöneshöfer.   

Abstract

Treatment of fifteen patients with essential hypertension over four weeks using the beta 1-adrenoceptor blocking agent, metoprolol, resulted in a decrease in 24 h urinary excretion of kallikrein and aldosterone along with a decrease in plasma renin activity. There was no significant change in 24 h excretion rates of the free adrenal steroids deoxycorticosterone, 18-OH-deoxycorticosterone, corticosterone, cortisol or 18-OH-corticosterone during treatment, which were not significantly different from excretion rates of normal males, thus excluding inhibitory effects of adrenal steroids on urinary kallikrein activity. A positive correlation was found between plasma renin activity and urinary excretion of kallikrein during the control period and after 2 weeks on metoprolol, supporting the assumption of a preserved link between the renin-angiotensin-aldosterone system and the renal excretion of kallikrein in these patients. The decrease in kallikrein excretion during beta 1-adrenoceptor blockade in patients with essential hypertension may be explained by a reduction in sympathetic tone and by reduced activity of the renin-aldosterone system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367871      PMCID: PMC1986883          DOI: 10.1111/j.1476-5381.1984.tb10071.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  57 in total

1.  Deoxycorticosterone excretion in normal, hypertensive and hypokalaemic subjects.

Authors:  C L Cope; S Loizou
Journal:  Clin Sci Mol Med       Date:  1975-02

2.  Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man.

Authors:  W Oelkers; M Schöneshöfer; A Blümel
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.

Authors:  H S Margolius; D Horwitz; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

5.  Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids.

Authors:  H S Margolius; D Horwitz; R G Geller; R W Alexander; J R Gill; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

6.  Relation between urinary kallikrein and renal function, hypertension, and excretion of sodium and water in man.

Authors:  A Adetuyibi; I H Mills
Journal:  Lancet       Date:  1972-07-29       Impact factor: 79.321

7.  Effects of mineralocorticoids, altered sodium intake, and adrenalectomy on urinary kallikrein in rats.

Authors:  R G Geller; H S Margolius; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1972-12       Impact factor: 17.367

8.  Evidence for an involvement of kinins in regulation of sodium excretion.

Authors:  M Marin-Grez; P Cottone; O A Carretero
Journal:  Am J Physiol       Date:  1972-10

9.  The relationship between kidney and urinary kininogenase.

Authors:  K Nustad
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

10.  Localization of kininogenase in the rat kidney.

Authors:  K Nustad
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

View more
  1 in total

1.  Renal kallikrein in diabetic patients with hypertension accompanied by nephropathy.

Authors:  T Baba; S Murabayashi; T Ishizaki; Y Ido; K Aoyagi; K Takebe
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.